381 related articles for article (PubMed ID: 30473770)
1. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.
Coarelli G; Brice A; Durr A
F1000Res; 2018; 7():. PubMed ID: 30473770
[No Abstract] [Full Text] [Related]
2. Spinocerebellar ataxias in Venezuela: genetic epidemiology and their most likely ethnic descent.
Paradisi I; Ikonomu V; Arias S
J Hum Genet; 2016 Mar; 61(3):215-22. PubMed ID: 26538302
[TBL] [Abstract][Full Text] [Related]
3. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
[TBL] [Abstract][Full Text] [Related]
5. The wide spectrum of spinocerebellar ataxias (SCAs).
Manto MU
Cerebellum; 2005; 4(1):2-6. PubMed ID: 15895552
[TBL] [Abstract][Full Text] [Related]
6. Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia.
Koutsis G; Pemble S; Sweeney MG; Paudel R; Wood NW; Panas M; Kladi A; Houlden H
J Neurol Sci; 2012 Jul; 318(1-2):178-80. PubMed ID: 22520093
[TBL] [Abstract][Full Text] [Related]
7. Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia.
Rajkiewicz M; Sułek-Piatkowska A; Krysa W; Zdzienicka E; Szirkowiec W; Zaremba J
Neurol Neurochir Pol; 2008; 42(6):497-504. PubMed ID: 19235102
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
9. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.
Gan SR; Wang J; Figueroa KP; Pulst SM; Tomishon D; Lee D; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
Tremor Other Hyperkinet Mov (N Y); 2017; 7():492. PubMed ID: 29057148
[TBL] [Abstract][Full Text] [Related]
10. MR Imaging in Spinocerebellar Ataxias: A Systematic Review.
Klaes A; Reckziegel E; Franca MC; Rezende TJ; Vedolin LM; Jardim LB; Saute JA
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1405-12. PubMed ID: 27173364
[TBL] [Abstract][Full Text] [Related]
11. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
[TBL] [Abstract][Full Text] [Related]
13. Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes.
de Castilhos RM; Furtado GV; Gheno TC; Schaeffer P; Russo A; Barsottini O; Pedroso JL; Salarini DZ; Vargas FR; de Lima MA; Godeiro C; Santana-da-Silva LC; Toralles MB; Santos S; van der Linden H; Wanderley HY; de Medeiros PF; Pereira ET; Ribeiro E; Saraiva-Pereira ML; Jardim LB;
Cerebellum; 2014 Feb; 13(1):17-28. PubMed ID: 23943520
[TBL] [Abstract][Full Text] [Related]
14. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Buijsen RAM; Toonen LJA; Gardiner SL; van Roon-Mom WMC
Neurotherapeutics; 2019 Apr; 16(2):263-286. PubMed ID: 30607747
[TBL] [Abstract][Full Text] [Related]
15. Dystonia and ataxia progression in spinocerebellar ataxias.
Kuo PH; Gan SR; Wang J; Lo RY; Figueroa KP; Tomishon D; Pulst SM; Perlman S; Wilmot G; Gomez CM; Schmahmann JD; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
Parkinsonism Relat Disord; 2017 Dec; 45():75-80. PubMed ID: 29089256
[TBL] [Abstract][Full Text] [Related]
16. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.
Lin YC; Lee YC; Hsu TY; Liao YC; Soong BW
Parkinsonism Relat Disord; 2019 May; 62():156-162. PubMed ID: 30591349
[TBL] [Abstract][Full Text] [Related]
17. Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Paulson HL; Shakkottai VG; Clark HB; Orr HT
Nat Rev Neurosci; 2017 Oct; 18(10):613-626. PubMed ID: 28855740
[TBL] [Abstract][Full Text] [Related]
18. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias.
Szpisjak L; Zadori D; Klivenyi P; Vecsei L
CNS Neurol Disord Drug Targets; 2019; 18(4):279-293. PubMed ID: 30864514
[TBL] [Abstract][Full Text] [Related]
20. Brain pathology of spinocerebellar ataxias.
Seidel K; Siswanto S; Brunt ER; den Dunnen W; Korf HW; Rüb U
Acta Neuropathol; 2012 Jul; 124(1):1-21. PubMed ID: 22684686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
